Raelin Fullmer I

Raelin Fullmer practices at Legacy Meridian Park Medical Center in Tualatin, Oregon, part of Legacy Health.

Raelin Fullmer's NPI, 1528487956, was assigned on April 14, 2014. Raelin Fullmer holds Oregon license DO193586.

Raelin Fullmer's primary practice is Legacy Meridian Park Medical Center, at 19300 Sw 65th Avenue, Tualatin, OR 97062 in Washington County. The practice phone is (503) 692-1212.

Raelin Fullmer's primary practice is Legacy Meridian Park Medical Center in Tualatin, Oregon, part of Legacy Health. The medical group on file is Legacy Medical Group-Northwest. Dmand AI also links Raelin Fullmer to 1 more clinical lab, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Raelin Fullmer practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Raelin Fullmer's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Raelin Fullmer is licensed in Oregon.

CMS data shows 354 Medicare services from Raelin Fullmer across 4 procedure codes in 2024, for 157 Medicare patients. Medicare paid $32,591 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Raelin Fullmer in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Raelin Fullmer's median patient age at 77, with 58% women.

In 2024, Raelin Fullmer wrote 191 Medicare Part D claims for 82 patients. 90% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $131 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Raelin Fullmer for performance year 2024, reported through an alternative payment model (APM). Raelin Fullmer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Raelin Fullmer from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $17.